MARKET

BIAF

BIAF

bioAffinity Tech
NASDAQ
2.910
-0.090
-3.00%
After Hours: 2.880 -0.03 -1.03% 19:53 09/30 EDT
OPEN
2.800
PREV CLOSE
3.000
HIGH
3.070
LOW
2.800
VOLUME
393.04K
TURNOVER
0
52 WEEK HIGH
15.55
52 WEEK LOW
2.021
MARKET CAP
7.94M
P/E (TTM)
-0.9175
1D
5D
1M
3M
1Y
5Y
Why Amylyx Pharmaceuticals Is Trading Higher By Over 8%; Here Are 22 Stocks Moving Premarket
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) rose 42% to $3.21 in pre-market trading after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
Benzinga · 2d ago
CarMax, XPeng, Carvana among premarket losers' pack
SOBR Safe (SOBR) -32% has <a href="https://seekingalpha.com/news/3886931-sobr-safe...
Seekingalpha · 3d ago
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
Benzinga · 3d ago
Why Is BioAffinity (BIAF) Stock Up 40% Today?
Investor Place · 3d ago
Nasdaq Surges Over 150 Points; Gold Rises 2%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Wednesday.
Benzinga · 3d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers
Benzinga · 3d ago
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers
Benzinga · 3d ago
Dow Jumps 300 Points; Crude Oil Rises Sharply
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.
Benzinga · 3d ago
More
About BIAF
bioAffinity Technologies, Inc. is a biotechnology company. The Company focuses on the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer therapeutics. The Company has developed a proprietary platform, called CyPath, for in vitro diagnostics, the first of which is a noninvasive test for early detection of lung cancer called CyPath Lung. CyPath Lung detects lung cancer and the platform, which is developed to detect other forms of cancer and lung diseases. Its OncoSelect therapies are being developed based on novel discoveries shown in vitro to kill cancer lung, breast, brain, skin, and prostate cells without apparent harm to normal cells. The Company’s diagnostic tests are based on platform technologies that is applicable for detecting other lung diseases, such as chronic obstructive pulmonary disease (COPD) and asthma and diagnosing other types of cancer, such as prostate and bladder cancers.

Webull offers kinds of bioAffinity Technologies Inc stock information, including NASDAQ:BIAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIAF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIAF stock methods without spending real money on the virtual paper trading platform.